Mondrian Investment Partners LTD Buys New Stake in HCA Healthcare, Inc. $HCA

Mondrian Investment Partners LTD acquired a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA) in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 250,130 shares of the company’s stock, valued at approximately $106,605,000. HCA Healthcare comprises about 1.8% of Mondrian Investment Partners LTD’s investment portfolio, making the stock its 27th largest position.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Norges Bank purchased a new stake in shares of HCA Healthcare during the 2nd quarter worth approximately $1,152,408,000. Viking Global Investors LP grew its holdings in shares of HCA Healthcare by 58.5% in the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock valued at $717,214,000 after purchasing an additional 690,773 shares in the last quarter. Nordea Investment Management AB lifted its position in HCA Healthcare by 5.2% during the third quarter. Nordea Investment Management AB now owns 975,741 shares of the company’s stock valued at $415,656,000 after purchasing an additional 47,960 shares during the last quarter. Pacer Advisors Inc. increased its holdings in shares of HCA Healthcare by 6,115.3% in the 3rd quarter. Pacer Advisors Inc. now owns 911,096 shares of the company’s stock worth $388,309,000 after buying an additional 896,437 shares during the last quarter. Finally, LSV Asset Management lifted its holdings in shares of HCA Healthcare by 0.4% in the 2nd quarter. LSV Asset Management now owns 868,849 shares of the company’s stock valued at $332,856,000 after acquiring an additional 3,396 shares during the last quarter. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Stock Performance

Shares of NYSE:HCA opened at $539.91 on Tuesday. The firm has a market cap of $120.73 billion, a PE ratio of 19.02, a price-to-earnings-growth ratio of 1.66 and a beta of 1.36. The firm’s 50 day simple moving average is $483.90 and its 200-day simple moving average is $450.93. HCA Healthcare, Inc. has a one year low of $295.00 and a one year high of $552.90.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, topping the consensus estimate of $7.37 by $0.64. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The company had revenue of $19.51 billion for the quarter, compared to the consensus estimate of $19.67 billion. During the same period last year, the business posted $6.22 EPS. HCA Healthcare’s quarterly revenue was up 6.7% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Equities research analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th will be given a dividend of $0.78 per share. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. The ex-dividend date of this dividend is Tuesday, March 17th. This represents a $3.12 dividend on an annualized basis and a yield of 0.6%. HCA Healthcare’s payout ratio is 10.15%.

Insider Activity

In related news, EVP Michael S. Cuffe sold 1,500 shares of the company’s stock in a transaction on Tuesday, February 3rd. The stock was sold at an average price of $498.09, for a total transaction of $747,135.00. Following the completion of the sale, the executive vice president directly owned 30,003 shares in the company, valued at $14,944,194.27. This represents a 4.76% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, SVP Christopher F. Wyatt sold 4,000 shares of the business’s stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $505.00, for a total transaction of $2,020,000.00. Following the completion of the transaction, the senior vice president owned 44,379 shares of the company’s stock, valued at $22,411,395. This represents a 8.27% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 13,520 shares of company stock worth $6,894,067. Corporate insiders own 1.30% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the company. Raymond James Financial set a $525.00 price objective on HCA Healthcare in a research note on Monday, October 27th. UBS Group lifted their price objective on shares of HCA Healthcare from $525.00 to $598.00 and gave the stock a “buy” rating in a research note on Wednesday, January 28th. Argus raised their target price on shares of HCA Healthcare from $530.00 to $560.00 and gave the stock a “buy” rating in a report on Friday, February 6th. Jefferies Financial Group increased their price objective on shares of HCA Healthcare from $535.00 to $590.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. Finally, Oppenheimer upped their target price on HCA Healthcare from $500.00 to $540.00 and gave the company an “outperform” rating in a research note on Wednesday, January 28th. Sixteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $523.27.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.